GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DBV Technologies SA (FRA:DBV1) » Definitions » Future 3-5Y EPS without NRI Growth Rate

DBV Technologies (FRA:DBV1) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 19, 2025)


View and export this data going back to 2014. Start your Free Trial

What is DBV Technologies Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, DBV Technologies's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of DBV Technologies's Future 3-5Y EPS without NRI Growth Rate

For the Biotechnology subindustry, DBV Technologies's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DBV Technologies's Future 3-5Y EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DBV Technologies's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where DBV Technologies's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

DBV Technologies  (FRA:DBV1) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

DBV Technologies Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of DBV Technologies's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

DBV Technologies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DBV Technologies SA (FRA:DBV1) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
XPAR:ALCLS XPAR:GNFT XPAR:IPH XPAR:NANO XPAR:OSE XPAR:IVA XPAR:MAAT XPAR:TNG XPAR:ADOC XPAR:ALSEN VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
DBVT:USA 0QAJ:UK DBV:France DBV:Germany DBV:Germany
Address
107 Avenue de la Republique, Batiment IRO, Chatillon, Paris, FRA, 92320
Website
https://www.dbv-technologies.com
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

DBV Technologies Headlines

No Headlines